Our Impact
The Juliana Greenfield Family Foundation has funded more than $400,000 in neuroblastoma research and programs. The following are current research projects funded by The Juliana Greenfield Family Foundation:
Dana-Farber Cancer Institute/Boston Children’s Hospital
Dr. Robbie Majzner, MD, Director of the Pediatric and Young Adult Cancer Cell Therapy Program
First of its kind trial in the nation of a new GD2 CAR T cell trial for neuroblastoma
Memorial Sloan Kettering Cancer Center Department of Pediatrics
Dr. Brian H. Kushner, MD and Dr. Shakeel Modak, MD, Chief of the Neuroblastoma Service
N9 Pilot Study of Shortened Induction Chemotherapy
N10 phase 2 trial to test whether adding an anti-GD2 monoclonal antibody, naxitamab or Danyelza®, to the N9 regimen can further improve patient outcomes
Trial Report Coming Soon
University of Chicago Medicine Comer Children’s Hospital
Dr. Ami Desai, MD, MSCE and Dr. Susan L. Cohn, MD, Director of Clinical Research in the Department of Pediatrics
Trial for a new Treatment Regimen that Combines Immunotherapy with Stereotactic Body Radiation Therapy (SBRT).
Future Goals
Looking ahead, The Juliana Greenfield Family Foundation is committed to funding additional trials being led by the nation’s foremost experts in neuroblastoma. Increased funding and awareness are vital to the hopeful discovery of more effective treatments and edge closer to a cure.
